Furthr VC
VC Fund
Dublin, Ireland
Furthr VC is a VC fund in Dublin focused on Software and Medical Device. We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $36M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Furthr VC invests in
Stages Furthr VC invests in
Countries Furthr VC invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $797k–$6.3M
- Venture - Series Unknown
- $753k–$17M
Investment Focus
Industry
- Software 8 (26%)
- Medical Device 6 (19%)
- Medical 5 (16%)
- Health Care 4 (13%)
- FinTech 3 (10%)
Stage
- Seed 16 (52%)
- Venture - Series Unknown 6 (19%)
- Funding Round 3 (10%)
- Pre-Seed 2 (6%)
- Series A 2 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Richard Watson
Managing Partner
|
Managing Partner | Total investments: 14 | Find email | |
Colm O'Sullivan
Managing Partner
|
Managing Partner | Total investments: 11 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Wrxflo provides software solutions that connect operations and management systems, visualizing data through customizable dashboards. The company specializes in business and productivity software, offering an IoT platform tailored for the manufacturing industry. Wrxflo's solutions enable businesses to access and manage their data efficiently,enhancing operational insights and decision-making processes. | $3.4M / Venture - Series Unknown / Jul 07, 2026 | ||
| NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside. | $5.5M / Jun 29, 2026 | ||
| Trustap is a transaction platform specifically designed to protect buyers and seller when they're transacting online or in person with strangers. The app is designed act as a third party between unknown parties to make sure transactions finish successfully and without either party being scammed. The platform works like an escrow service,holding funds securely until both parties are satisfied with the transaction. | $10M / Venture - Series Unknown / Jun 10, 2026 | ||
| LaNua Medical develop disruptive image-guided technologies providing safe and effective endovascular solutions. | $6.3M / Seed / Dec 12, 2024 | ||
| Trustap is a transaction platform specifically designed to protect buyers and seller when they're transacting online or in person with strangers. The app is designed act as a third party between unknown parties to make sure transactions finish successfully and without either party being scammed. The platform works like an escrow service,holding funds securely until both parties are satisfied with the transaction. | $5.5M / Series A / Jul 09, 2024 | ||
| STRATxAI is a WealthTech Company based in Dublin, Ireland. Specialising in AI-driven model portfolios, combining decades of expertise with proprietary AI to serve Advisors and Institutional Investors. STRATxAI Model Portfolios are built to navigate market complexity and deliver attractive risk-adjusted returns. Through close collaboration withclients, we create bespoke portfolios tailored to their unique needs, preferences and risk profiles. Alana, our proprietary engine leverages advanced machine learning algorithms to streamline the implementation and management of adaptive. multi factor strategies. | $1.6M / Seed / May 21, 2024 | ||
| NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside. | $2.1M / Seed / Jan 08, 2024 | ||
| SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer. | $1.7M / Seed / Dec 21, 2023 | ||
| GreyScout protects your brand against online counterfeits, rogue websites, grey market operators, unauthorized resellers and more | $3.7M / Seed / Nov 09, 2023 | ||
| Trustap is a transaction platform specifically designed to protect buyers and seller when they're transacting online or in person with strangers. The app is designed act as a third party between unknown parties to make sure transactions finish successfully and without either party being scammed. The platform works like an escrow service,holding funds securely until both parties are satisfied with the transaction. | Apr 19, 2023 | ||
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Furthr VC invest in?
Furthr VC invests primarily in Software, Medical Device and Medical startups, most often at Seed and Venture - Series Unknown stage. Most of the 31 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Furthr VC invest in?
Furthr VC typically joins rounds of $797k–$6.3M at Seed and $753k–$17M at Venture - Series Unknown. These are whole funding-round sizes, not Furthr VC's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Furthr VC took part in.
How do I contact Furthr VC?
Public channels for Furthr VC include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Furthr VC?
The team at Furthr VC includes Richard Watson (Managing Partner) and Colm O'Sullivan (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
